Scientists seek to understand relationship between viral infections and cancer recurrence, and breast cancer survivors seek menopause-symptom relief.

by Marci A. Landsmann

New studies show cancer vaccine promise despite funding cuts, and researchers identify protein signature that helps predict lung cancer risk.

by Marci A. Landsmann

A targeted therapy nearly doubles overall survival in metastatic pancreatic cancer, and the FDA approves a bladder cancer treatment.

by Thomas Celona

ACS colorectal cancer screening guideline now includes a blood-based test, and GLP-1 therapies may reduce risk for cancer progression.

by Darlene Dobkowski

An antibody-drug conjugate is approved to treat early-stage breast cancer, and preventive blood thinners linked to fewer blood clots.

by Eric Fitzsimmons

A recent analysis examined whether CYP2D6 metabolism influences tamoxifen response. The answer isn’t entirely clear.

by Ashley P. Taylor

The FDA approved a therapy for bile duct cancer, and most older adults with stage IV lung cancer never receive systemic treatment.

by Thomas Celona

Research defines key behaviors for longevity in cancer survivors, but finding the balance between living by the rules and living your life isn’t always straightforward.

by Alexandra Frost

Findings signal targeted therapy effectiveness in pancreatic cancer, and new insights into the thymus’s role in cancer and health.

by Eric Fitzsimmons

Transgender and bisexual cancer survivors often face more obstacles to health care than lesbians and gay men.

by Tyler Santora